Literature DB >> 19399028

Obesity, inflammation, and atherosclerosis.

Viviane Z Rocha1, Peter Libby.   

Abstract

Understanding of the pathophysiology of atherogenesis has evolved substantially during the last few decades. Atherosclerosis was once identified as a lipid-storage disease, but is now recognized as a subacute inflammatory condition of the vessel wall, characterized by infiltration of macrophages and T cells, which interact with one another and with cells of the arterial wall. The pathological mechanisms of obesity recapitulate many features of the inflammatory processes at work in atherosclerosis. Our current appreciation of the similarities between obesity and atherosclerosis has already fostered innovations for the diagnosis, prognosis, and prevention of these two conditions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19399028     DOI: 10.1038/nrcardio.2009.55

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN: 1759-5002            Impact factor:   32.419


  115 in total

1.  Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans.

Authors:  Saverio Cinti; Grant Mitchell; Giorgio Barbatelli; Incoronata Murano; Enzo Ceresi; Emanuela Faloia; Shupei Wang; Melanie Fortier; Andrew S Greenberg; Martin S Obin
Journal:  J Lipid Res       Date:  2005-09-08       Impact factor: 5.922

2.  Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events.

Authors:  P M Ridker; N Rifai; M Clearfield; J R Downs; S E Weis; J S Miles; A M Gotto
Journal:  N Engl J Med       Date:  2001-06-28       Impact factor: 91.245

Review 3.  Role of oxidized low density lipoprotein in atherogenesis.

Authors:  J L Witztum; D Steinberg
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

Review 4.  The immune response in atherosclerosis: a double-edged sword.

Authors:  Göran K Hansson; Peter Libby
Journal:  Nat Rev Immunol       Date:  2006-06-16       Impact factor: 53.106

Review 5.  Thematic review series: the pathogenesis of atherosclerosis. An interpretive history of the cholesterol controversy, part V: the discovery of the statins and the end of the controversy.

Authors:  Daniel Steinberg
Journal:  J Lipid Res       Date:  2006-04-03       Impact factor: 5.922

Review 6.  Atherosclerosis--an immune disease: The Anitschkov Lecture 2007.

Authors:  Göran K Hansson
Journal:  Atherosclerosis       Date:  2008-09-06       Impact factor: 5.162

7.  Inhibition of CCR2 ameliorates insulin resistance and hepatic steatosis in db/db mice.

Authors:  Yukinori Tamura; Masayuki Sugimoto; Toshinori Murayama; Yukihiko Ueda; Hiroshi Kanamori; Koh Ono; Hiroyuki Ariyasu; Takashi Akamizu; Toru Kita; Masayuki Yokode; Hidenori Arai
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-09-25       Impact factor: 8.311

8.  A novel RANTES antagonist prevents progression of established atherosclerotic lesions in mice.

Authors:  Vincent Braunersreuther; Sabine Steffens; Claire Arnaud; Graziano Pelli; Fabienne Burger; Amanda Proudfoot; François Mach
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-04-03       Impact factor: 8.311

9.  Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance.

Authors:  G S Hotamisligil; N S Shargill; B M Spiegelman
Journal:  Science       Date:  1993-01-01       Impact factor: 47.728

10.  Monocyte chemoattractant protein deficiency fails to restrain macrophage infiltration into adipose tissue [corrected].

Authors:  Elizabeth A Kirk; Zachary K Sagawa; Thomas O McDonald; Kevin D O'Brien; Jay W Heinecke
Journal:  Diabetes       Date:  2008-02-11       Impact factor: 9.461

View more
  293 in total

1.  Platelets, glycoprotein Ib-IX, and von Willebrand factor are required for FeCl(3)-induced occlusive thrombus formation in the inferior vena cava of mice.

Authors:  M V Joglekar; Jerry Ware; Jin Xu; Malinda E C Fitzgerald; Theodore Kent Gartner
Journal:  Platelets       Date:  2012-06-21       Impact factor: 3.862

Review 2.  Novel lipid mediators promote resolution of acute inflammation: impact of aspirin and statins.

Authors:  Matthew Spite; Charles N Serhan
Journal:  Circ Res       Date:  2010-11-12       Impact factor: 17.367

3.  Treatment with chondroitin sulfate to modulate inflammation and atherogenesis in obesity.

Authors:  Pedro Melgar-Lesmes; Fernando Garcia-Polite; Paula Del-Rey-Puech; Elisabet Rosas; Juliana L Dreyfuss; Eulàlia Montell; Josep Vergés; Elazer R Edelman; Mercedes Balcells
Journal:  Atherosclerosis       Date:  2015-12-13       Impact factor: 5.162

4.  Soraphen A, an inhibitor of acetyl CoA carboxylase activity, interferes with fatty acid elongation.

Authors:  Donald B Jump; Moises Torres-Gonzalez; L Karl Olson
Journal:  Biochem Pharmacol       Date:  2010-12-22       Impact factor: 5.858

5.  Suppression of PPARγ through MKRN1-mediated ubiquitination and degradation prevents adipocyte differentiation.

Authors:  J-H Kim; K W Park; E-W Lee; W-S Jang; J Seo; S Shin; K-A Hwang; J Song
Journal:  Cell Death Differ       Date:  2013-12-13       Impact factor: 15.828

Review 6.  Effects of opium consumption on cardiometabolic diseases.

Authors:  Farzad Masoudkabir; Nizal Sarrafzadegan; Mark J Eisenberg
Journal:  Nat Rev Cardiol       Date:  2013-10-22       Impact factor: 32.419

7.  Dietary apigenin reduces LPS-induced expression of miR-155 restoring immune balance during inflammation.

Authors:  Daniel Arango; Mayra Diosa-Toro; Laura S Rojas-Hernandez; Jessica L Cooperstone; Steven J Schwartz; Xiaokui Mo; Jinmai Jiang; Thomas D Schmittgen; Andrea I Doseff
Journal:  Mol Nutr Food Res       Date:  2015-02-23       Impact factor: 5.914

8.  Myeloid Krüppel-like factor 4 deficiency augments atherogenesis in ApoE-/- mice--brief report.

Authors:  Nikunj Sharma; Yuan Lu; Guangjin Zhou; Xudong Liao; Parul Kapil; Puneet Anand; Ganapati H Mahabeleshwar; Jonathan S Stamler; Mukesh K Jain
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-10-11       Impact factor: 8.311

9.  Alterations of a Cellular Cholesterol Metabolism Network Are a Molecular Feature of Obesity-Related Type 2 Diabetes and Cardiovascular Disease.

Authors:  Jingzhong Ding; Lindsay M Reynolds; Tanja Zeller; Christian Müller; Kurt Lohman; Barbara J Nicklas; Stephen B Kritchevsky; Zhiqing Huang; Alberto de la Fuente; Nicola Soranzo; Robert E Settlage; Chia-Chi Chuang; Timothy Howard; Ning Xu; Mark O Goodarzi; Y-D Ida Chen; Jerome I Rotter; David S Siscovick; John S Parks; Susan Murphy; David R Jacobs; Wendy Post; Russell P Tracy; Philipp S Wild; Stefan Blankenberg; Ina Hoeschele; David Herrington; Charles E McCall; Yongmei Liu
Journal:  Diabetes       Date:  2015-07-07       Impact factor: 9.461

Review 10.  From Heartbreak to Heart Disease: A Narrative Review on Depression as an Adjunct to Cardiovascular Disease.

Authors:  Jahanzeb Malik; Hamid Sharif Khan; Faizan Younus; Muhammad Shoaib
Journal:  Pulse (Basel)       Date:  2021-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.